Product Information
MEXILETINE 150 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2266 per EA under NDC 00093873901. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on May 16, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093873901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074377FDA Approved
5/16/1995
TE Code
AB
On Market Since
6/5/1995
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 150 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2266 per EA |
|---|---|
| All-time high | $0.9583 (Nov 11, 2020) |
| All-time low | $0.2193 (Jul 17, 2024) |
| 52-week high | $0.2727 |
| 52-week low | $0.2266 |
| Median price | $0.6525 |
| Average price | $0.5906 |
| Largest weekly change | +92.0% (Oct 15, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEXILETINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 150 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.2266 per EA (NDC 00093873901), effective Aug 19, 2026.
How has the price of MEXILETINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 150 MG CAPSULE has declined 19.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEXILETINE 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MEXILETINE 150 MG CAPSULE has ranged from a low of $0.2193 (Jul 17, 2024) to a high of $0.9583 (Nov 11, 2020), with a median of $0.6525 per EA.
Are there cheaper alternatives to MEXILETINE 150 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEXILETINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEXILETINE 150 MG CAPSULE?
MEXILETINE 150 MG CAPSULE (NDC 00093873901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.